Your browser doesn't support javascript.
loading
[Central neurocytomas: surgical treatment outcomes and new trends and approaches in the treatment]. / Tsentral'nye neirotsitomy golovnogo mozga: rezul'taty khirurgicheskogo lecheniia i novye tendentsii i strategii v lechenii.
Konovalov, A N; Maryashev, S A; Pitskhelauri, D I; Lubnin, A Yu.
Afiliação
  • Konovalov AN; Burdenko Neurosurgical Center, Moscow, Russia.
  • Maryashev SA; Burdenko Neurosurgical Center, Moscow, Russia.
  • Pitskhelauri DI; Burdenko Neurosurgical Center, Moscow, Russia.
  • Lubnin AY; Burdenko Neurosurgical Center, Moscow, Russia.
Article em Ru | MEDLINE | ID: mdl-32031164
ABSTRACT

AIM:

Central neurocytomas of the brain are rare benign tumors of the cerebral lateral ventricles. The main treatment for them is surgical resection. Resection provides a long-term relapse-free period, but surgical intervention is associated with a number of significant difficulties due to the location, size, and blood supply features of these tumors. The postoperative period is often accompanied by hemorrhagic complications, impaired cerebrospinal fluid circulation, and worsening of neurological symptoms.

PURPOSE:

The study purpose was to evaluate the effectiveness of surgical treatment in neurocytoma patients, assess the risk of complications after neurocytoma resection, and develop techniques for their prevention. MATERIAL AND

METHODS:

The paper presents surgical treatment outcomes in 115 patients with central neurocytomas for the period from 2008 to 2017. The choice of a surgical approach and the surgical features are described in detail, and the radicality is assessed with allowance for the location and size of tumors. The immediate clinical outcomes of treatment are evaluated, complications are analyzed, and methods for prevention and treatment of complications are described.

RESULTS:

Analysis of the data revealed that the tumor was resected totally in 41 (36%) patients, subtotally - in 37 (32%), and partially in 37 (32%). The most common and dangerous complications were as follows CSF circulation occlusion with the development of hydrocephalus in 23 (20%) patients; hemorrhage into the residual tumor, which required immediate revision of the surgical wound in most cases, in 25 (22%) patients. In the early postoperative period after tumor resection, almost all patients developed deterioration of condition with transient worsening of cerebral and focal symptoms. The degree and duration of this worsening were different. In 50% of cases, the postoperative condition was characterized by reduced voluntary activity, drowsiness or jitteriness, and motor or speech anxiety.

CONCLUSION:

We consider resection of neurocytomas as the main treatment option, despite the potential complications and effects of the operation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neurocitoma Tipo de estudo: Observational_studies Limite: Humans Idioma: Ru Revista: Zh Vopr Neirokhir Im N N Burdenko Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Federação Russa

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neurocitoma Tipo de estudo: Observational_studies Limite: Humans Idioma: Ru Revista: Zh Vopr Neirokhir Im N N Burdenko Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Federação Russa